Toggle Health Problems and D

IOM finally responds to Endocrine Society on Vitamin levels – March 2012.

IOM Committee Members Respond to Endocrine Society Vitamin D Guideline.

J Clin Endocrinol Metab. 2012 Mar 22.
Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL.

Maine Medical Center Research Institute, Scarbrough, Maine 04074;
Baylor College of Medicine, Houston, Texas 77030; State University of New York at Stony Brook and Winthrop-University Hospital, Mineola, New York, 11501;
Cornell University, Ithaca, New York 14853;
The Ohio State University, Columbus, Ohio 43210; Loyola University Chicago, Maywood, Illinois 60153;
Creighton University Medical Center, Omaha, Nebraska 68131;
University of California, San Diego, San Diego, California 92161;
Queens University, Kingston, Ontario, Canada K7L 3N6;
Memorial University of Newfoundland, St. John's, Newfoundland, Canada A1B 3V6;
Harvard Medical School, Boston, Massachusetts 02215;
Yale School of Public Health, New Haven, Connecticut 06520;
The Pennsylvania State University, University Park, Pennsylvania 16802;
and Rutgers University, The State University of New Jersey, New Brunswick, New Jersey 08901;
Office of Dietary Supplements (C.L.T.), The National Institutes of Health, Bethesda, Maryland 20892.
.
In early 2011, a committee convened by the Institute of Medicine issued a report on the Dietary Reference Intakes for calcium and vitamin D. The Endocrine Society Task Force in July 2011 published a guideline for the evaluation, treatment, and prevention of vitamin D deficiency. Although these reports are intended for different purposes, the disagreements concerning the nature of the available data and the resulting conclusions have caused confusion for clinicians, researchers, and the public.

In this commentary, members of the Institute of Medicine committee respond to aspects of The Endocrine Society guideline that are not well supported and in need of reconsideration. These concerns focus on target serum 25-hydroxyvitamin D levels, the definition of vitamin D deficiency, and the question of who constitutes a population at risk vs. the general population.

PMID: 22442278
- - - - - - - - - - -
Wish that the abstract had more information

See also VitaminDWiki

IoM and Endocine recommendations graph